EUVIMED · CrossrefJournal
The Brown University Psychopharmacology Update
ISSN 1068-5308 · Wiley
Latest articles
Study finds GLP‐1 RAs reduced 4‐year mortality by 24% compared to SGLT2 inhibitors in people with SMI
Meta‐analysis shows rapid relapse after antipsychotic discontinuation linked to baseline severity, not withdrawal
Antidepressant use during pregnancy benefits mothers with pre‐existing depression
Single‐dose psilocybin superior to placebo for MDD in community setting
Ketamine found safe and effective for treatment‐resistant bipolar depression in small trial
Pilot study supports broader research on psilocybin for anorexia nervosa
Menopausal hormone therapy may protect against Alzheimer's disease
Risks of lithium toxicity in patients taking ACEi or ARB medications no greater than those taking beta blockers: Cohort study
Aripiprazole associated with lower risk of hyponatremia than olanzapine
SGLT2 inhibitors improve kidney function in lithium‐treated patients
Buprenorphine‐naloxone after opioid withdrawal treatment reduces overdose risk
Single dose of psilocybin shows extended benefit in depression trial
Potentially inappropriate medications in the elderly
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
Table of Contents
EUVIMED